Biologics recommendations for patients with psoriasis: a critical appraisal of clinical practice guidelines for psoriasis

References

• Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70:512–516.
   PubMed Web of Science ®Google Scholar
• Yeung H, Takeshita J, Mehta NN, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013;149:1173–1179.
   PubMed Web of Science ®Google Scholar
• Lebwohl MG, Kavanaugh A, Armstrong AW, et al. US perspectives in the management of psoriasis and psoriatic arthritis: patient and physician results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Am J Clin Dermatol. 2016;17:87–97.
   PubMed Web of Science ®Google Scholar
• Kurd SK, Troxel AB, Crits-Christoph P, et al. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146:891–895.
   PubMed Web of Science ®Google Scholar
• Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc. 2013;2:e000062.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Robertson AD, Wu J, et al. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. JAMA Dermatol. 2013; 149:1180–1185.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Schupp C, Wu J, et al. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011. PLoS One. 2012;7:e52935.
   PubMed Web of Science ®Google Scholar
• Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401–407.
   PubMed Web of Science ®Google Scholar
• Schmitt J, Rosumeck S, Thomaschewski G, et al. Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br J Dermatol. 2014;170:274–303.
   PubMed Web of Science ®Google Scholar
• Graham RMM, Miller Wolman D, Greenfield S, et al. Clinical practice guidelines we can trust. Institute of Medicine (US) Committee on Standards for developing trustworthy clinical practice guidelines. Washington (DC): The National Academies press (US); 2011.
   Google Scholar
• AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003;12:18–23.
   PubMed Web of Science ®Google Scholar
• Brouwers MC, Kho ME, Browman GP, et al. AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting, and evaluation in health care. Prev Med. 2010;51:421–424.
   PubMed Web of Science ®Google Scholar
• Doherty SD, Van Voorhees A, Lebwohl MG, et al. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents. J Am Acad Dermatol. 2008;59:209–217.
   PubMed Web of Science ®Google Scholar
• Elmets CA, Korman NJ, Prater EF, et al. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021;84:432–470.
   PubMed Web of Science ®Google Scholar
• Elmets CA, Leonardi CL, Davis DMR, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019;80:1073–1113.
   PubMed Web of Science ®Google Scholar
• Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80:1029–1072.
   PubMed Web of Science ®Google Scholar
• Menter A, Gelfand JM, Connor C, et al. Joint AAD-NPF guidelines of care for the management of psoriasis with systemic non-biological therapies. J Am Acad Dermatol. 2020;82:1445–1486.
   PubMed Web of Science ®Google Scholar
• Elmets CA, Lim HW, Stoff B, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. J Am Acad Dermatol. 2019;81:775–804.
   PubMed Web of Science ®Google Scholar
• Singh JA, Guyatt G, Ogdie A, et al. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Care Res. 2019;71:2–29.
   PubMed Web of Science ®Google Scholar
• Puig L, Carrascosa JM, Carretero G, et al. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Actas Dermosifiliogr. 2013;104:694–709.
   PubMedGoogle Scholar
• Sánchez-Regaña M, Aldunce Soto MJ, Belinchón Romero I, et al. Evidence-based guidelines of the Spanish Psoriasis Group on the use of biologic therapy in patients with psoriasis in difficult-to-treat sites (nails, scalp, palms, and soles). Actas Dermosifiliogr. 2014;105:923–934.
   PubMedGoogle Scholar
• Osier E, Wang AS, Tollefson MM, et al. Pediatric Psoriasis Comorbidity Screening Guidelines. JAMA Dermatol. 2017;153:698–704.
   PubMed Web of Science ®Google Scholar
• Smith CH, Jabbar-Lopez ZK, Yiu ZZ, et al. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017. Br J Dermatol. 2017;177:628–636.
   PubMed Web of Science ®Google Scholar
• Arnone M, Takahashi MDF, Carvalho AVE, et al. Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology. An Bras Dermatol. 2019;94:76–107.
   PubMed Web of Science ®Google Scholar
• Kyle S, Chandler D, Griffiths CE, et al., British Society for Rheumatology Standards Guidelines Audit Working Group (SGAWG). Guideline for anti-TNF-alpha therapy in psoriatic arthritis. Rheumatology. 2005;44:390–397.
   PubMed Web of Science ®Google Scholar
• Coates LC, Tillett W, Chandler D, et al. BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR. The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. Rheumatology. 2013;52:1754–1757.
   PubMed Web of Science ®Google Scholar
• Roubille C, Richer V, Starnino T, et al. Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: expert opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative. J Rheumatol. 2015;42:1767–1780.
   PubMed Web of Science ®Google Scholar
• Canadian Psoriasis Guidelines Committee. Canadian Guidelines for the Management of Plaque Psoriasis. 2009. Available from: http://www.dermatology.ca/psoriasisguidelines
   Google Scholar
• Professional Committee of Dermatology of China Association of Chinese Medicine, Professional Committee of Dermatology of Beijing Association of Chinese Medicine, Professional Committee of Dermatology and Venereal Diseases of Beijing Association of Integrated Medicine. Evidence-based practice guidelines of traditional Chinese medicine of psoriasis vulgaris (2013). Beijing (China): People’s Medical Publishing House; 2013.
   Google Scholar
• Radtke MA, Mrowietz U, Feuerhahn J, et al. Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis. J Dtsch Dermatol Ges. 2015;13:674–690.
   PubMed Web of Science ®Google Scholar
• Nast A, Boehncke WH, Mrowietz U, et al. Berufsverband Deutscher Dermatologen (BVDD). S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges. 2012;10 Suppl 2:S1–S95.
   PubMed Web of Science ®Google Scholar
• Nast A, Spuls PI, van der Kraaij G, et al. European S3-Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2017;31:1951–1913.
   PubMed Web of Science ®Google Scholar
• Gisondi P, Altomare G, Ayala F, et al. Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol. 2017;31:774–790.
   PubMed Web of Science ®Google Scholar
• Nast A, Gisondi P, Ormerod AD, et al. European S3-Guidelines on the systemic treatment of psoriasis vulgaris-Update 2015-Short version-EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2015;29:2277–2294.
   PubMed Web of Science ®Google Scholar
• Richard MA, Barnetche T, Rouzaud M, et al. Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: systematic review and expert opinion. J Eur Acad Dermatol Venereol. 2014;28 Suppl 5:3–12.
   PubMed Web of Science ®Google Scholar
• Mrowietz U, de Jong EM, Kragballe K, et al. A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol. 2014;28:438–453.
   PubMed Web of Science ®Google Scholar
• Daudén E, Working Group on Comorbidity in Psoriasis, Castañeda S, Suárez C, et al. Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. J Eur Acad Dermatol Venereol. 2013;27:1387–1404.
   PubMed Web of Science ®Google Scholar
• Paul C, Gallini A, Archier E, et al. Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol. 2012;26 Suppl 3:1–10.
   PubMed Web of Science ®Google Scholar
• Paul C, Gallini A, Maza A, et al. Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol. 2011;25 Suppl 2:2–11.
   PubMed Web of Science ®Google Scholar
• Paul C, Gourraud PA, Bronsard V, et al. Evidence-based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol. 2010;24 Suppl 2:2–9.
   PubMed Web of Science ®Google Scholar
• Amatore F, Villani AP, Tauber M, et al. Psoriasis Research Group of the French Society of Dermatology (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie). French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults. J Eur Acad Dermatol Venereol. 2019;33:464–483.
   PubMed Web of Science ®Google Scholar
• Gossec L, Smolen JS, Ramiro S, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75:499–510.
   PubMed Web of Science ®Google Scholar
• Nash P, Lubrano E, Cauli A, et al. Updated guidelines for the management of axial disease in psoriatic arthritis. J Rheumatol. 2014;41:2286–2289.
   PubMed Web of Science ®Google Scholar
• Ritchlin CT, Kavanaugh A, Gladman DD, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Treatment recommendations for psoriatic arthritis. Ann Rheum Dis. 2009;68:1387–1394.
   PubMed Web of Science ®Google Scholar
• Fujita H, Terui T, Hayama K, et al. Japanese Dermatological Association Guidelines Development Committee for the Guidelines for the Management and Treatment of Generalized Pustular Psoriasis. Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP. J Dermatol. 2018;45:1235–1270.
   PubMed Web of Science ®Google Scholar
• Kogan N, Raimondo N, Gusis SE, et al. Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis SOLAPSO - Sociedad Latinoamericana de Psoriasis (Latin American Psoriasis Society). Int J Dermatol. 2019;58 Suppl 1:4–28.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Psoriasis: assessment and management (CG153). 2012. Available from: http://www.nice.org.uk/guidance/cg153
   Google Scholar
• Prussick R, Wu JJ, Armstrong AW, et al. Psoriasis in solid organ transplant patients: best practice recommendations from The Medical Board of the National Psoriasis Foundation. J Dermatolog Treat. 2018;29:329–333.
   PubMed Web of Science ®Google Scholar
• Crowley JJ, Weinberg JM, Wu JJ, et al. National Psoriasis Foundation. Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation. JAMA Dermatol. 2015;151:87–94.
   PubMed Web of Science ®Google Scholar
• Robinson A, Van Voorhees AS, Hsu S, et al. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2012;67:279–288.
   PubMed Web of Science ®Google Scholar
• Rosenbach M, Hsu S, Korman NJ, et al. National Psoriasis Foundation Medical Board. Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;62:655–662.
   PubMed Web of Science ®Google Scholar
• Frankel AJ, Van Voorhees AS, Hsu S, et al. National Psoriasis Foundation. Treatment of psoriasis in patients with hepatitis C: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009;61:1044–1055.
   PubMed Web of Science ®Google Scholar
• Chan CS, Van Voorhees AS, Lebwohl MG, et al. Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009;60:962–971.
   PubMed Web of Science ®Google Scholar
• Carneiro S, Azevedo VF, Bonfiglioli R, et al. Comissão de Espondiloartrites da Sociedade Brasileira de Reumatologia. Recommendations for the management and treatment of psoriatic arthritis. Rev Bras Reumatol. 2013;53:227–241.
   PubMedGoogle Scholar
• Spanish Society of Rheumatology. ESPOGUIA development group. Clinical Practice Guideline for Patients with Axial Spondyloarthritis and Psoriatic Arthritis. [monograph on the Internet]. Madrid (Spain): Spanish Society of Rheumatology. 2015.
   Google Scholar
• Juanola Roura X, Zarco Montejo P, Sanz Sanz J, et al. [Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in spondyloarthritis except for psoriatic arthritis]. Reumatol Clin. 2011;7:113–123.
   PubMedGoogle Scholar
• Fortina AB, Bardazzi F, Berti S, et al. Treatment of severe psoriasis in children: recommendations of an Italian expert group. Eur J Pediatr. 2017;176:1339–1354.
   PubMed Web of Science ®Google Scholar
• Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of psoriasis and psoriatic arthritis in adults. Edinburgh (UK): SIGN; 2010.
   Google Scholar
• Salvarani C, Pipitone N, Marchesoni A, et al. Italian Society for Rheumatology. Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-α blocking) agents in the treatment of psoriatic arthritis. Clin Exp Rheumatol. 2006;24:70–78.
   PubMed Web of Science ®Google Scholar
• Marchesoni A, Olivieri I, Salvarani C, et al. Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology. Clin Exp Rheumatol. 2017;35:991–1010.
   PubMed Web of Science ®Google Scholar
• Salliot C, Dernis E, Lavie F, et al. Diagnosis of peripheral psoriatic arthritis: recommendations for clinical practice based on data from the literature and experts opinion. Joint Bone Spine. 2009;76:532–539.
   PubMed Web of Science ®Google Scholar
• Vieira-Sousa E, Machado PM, Costa J, et al., Portuguese Society of Rheumatology. Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis–2015 update. Acta Reumatol Port. 2015;40:275–290.
   PubMed Web of Science ®Google Scholar
• Raboobee N, Working Group of the Dermatological Society of South Africa, Aboobaker J, Jordaan HF, et al. Guideline on the management of psoriasis in South Africa. S Afr Med J. 2010; Apr100:257–282.
   PubMedGoogle Scholar
• Shekelle PG, Woolf SH, Eccles M, et al. Clinical guidelines: developing guidelines. BMJ. 1999;318:593–510.
   PubMed Web of Science ®Google Scholar
• Jian-Ping L. The composition of evidence body of Tradional Chinese medicine and recommendations for its evidence grading. CJITWM. 2007;27:1061–1065.
   Google Scholar
• Woolf SH, Grol R, Hutchinson A, et al. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318:527–530.
   PubMed Web of Science ®Google Scholar
• Krahn M, Naglie G. The next step in guideline development: incorporating patient preferences. J Am Med Assoc. 2008;300:436–438.
   PubMed Web of Science ®Google Scholar
• Nast A, Spuls PH, Ormerod AD, et al. A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: ‘AGREE-ing’ on a common base for European evidence-based psoriasis treatment guidelines . J Eur Acad Dermatol Venereol. 2009;23:782–787.
   PubMed Web of Science ®Google Scholar
• Tan JK, Wolfe BJ, Bulatovic R, et al. Critical appraisal of quality of clinical practice guidelines for treatment of psoriasis vulgaris, 2006-2009. J Invest Dermatol. 2010; Oct130:2389–2395.
   PubMed Web of Science ®Google Scholar
• Alonso-Coello P, Irfan A, Solà I, et al. The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. Qual Saf Health Care. 2010; 19:e58–7.
   PubMedGoogle Scholar